Higher doses doses of aspirin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

Blood Platelets Gastric Mucosa Liver

Organisms3

Rats, Sprague-Dawley Rats, Wistar Dogs

Diseases13

Hemorrhage Asthma, Aspirin-Induced Gastrointestinal Hemorrhage Thrombosis Myocardial Infarction Stomach Ulcer Neoplasms Recurrence Stroke Disease Models, Animal Drug Hypersensitivity Reye Syndrome Radiation Injuries

Chemicals and Drugs34

Aspirin Platelet Aggregation Inhibitors Anti-Inflammatory Agents, Non-Steroidal Ticlopidine Thromboxane B2 Cyclooxygenase Inhibitors Salicylates Sodium Salicylate Warfarin Anticoagulants Fibrinolytic Agents Tablets, Enteric-Coated Ibuprofen Cyclooxygenase 1 Acetaminophen Prostaglandin-Endoperoxide Synthases Thromboxanes Cyclooxygenase 2 Inhibitors Thromboxane A2 Dipyridamole Drug Combinations Lipoxins Prostaglandins Cyclooxygenase 2 Antineoplastic Agents Sulfinpyrazone Naproxen Placebos Indomethacin Dinoprostone Heparin Epoprostenol Salicylic Acid Pyrazoles

Analytical, Diagnostic and Therapeutic Techniques and Equipment35

Drug Administration Schedule Radiation Dosage Lethal Dose 50 Administration, Oral Drug Therapy, Combination Double-Blind Method Treatment Outcome Platelet Function Tests Radiometry Dose-Response Relationship, Radiation Dose Fractionation Radiotherapy Dosage Injections, Intravenous Prospective Studies Bleeding Time Infusions, Intravenous Area Under Curve Radiotherapy Planning, Computer-Assisted Risk Factors Follow-Up Studies Body Burden Thermoluminescent Dosimetry Drug Evaluation Injections, Subcutaneous Disease Models, Animal Random Allocation Placebos Metabolic Clearance Rate Risk Assessment Metered Dose Inhalers Randomized Controlled Trials as Topic Radiation Monitoring Retrospective Studies Clinical Trials as Topic Antineoplastic Combined Chemotherapy Protocols

Phenomena and Processes15

Radiation Dosage Lethal Dose 50 Platelet Aggregation Time Factors Drug Interactions Dose-Response Relationship, Radiation Bleeding Time Area Under Curve Platelet Activation Drug Resistance Half-Life Dose-Response Relationship, Drug Drug Synergism Biological Availability Metabolic Clearance Rate

Information Science1

Radiotherapy Planning, Computer-Assisted

Health Care19

Radiation Dosage Double-Blind Method Treatment Outcome Dose-Response Relationship, Radiation Prospective Studies Area Under Curve Risk Factors Follow-Up Studies Body Burden Thermoluminescent Dosimetry Relative Biological Effectiveness Random Allocation Risk Assessment Randomized Controlled Trials as Topic Radiation Monitoring Retrospective Studies Radiation Injuries Clinical Trials as Topic Primary Prevention

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Health Care

Aspirin Platelet Aggregation Inhibitors Anti-Inflammatory Agents, Non-Steroidal Ticlopidine Thromboxane B2 Drug Administration Schedule Radiation Dosage Lethal Dose 50 Cyclooxygenase Inhibitors Administration, Oral Drug Therapy, Combination Platelet Aggregation Double-Blind Method Time Factors Salicylates Treatment Outcome Platelet Function Tests Radiometry Blood Platelets Drug Interactions Sodium Salicylate Warfarin Anticoagulants Dose-Response Relationship, Radiation Dose Fractionation Hemorrhage Radiotherapy Dosage Injections, Intravenous Fibrinolytic Agents Prospective Studies Tablets, Enteric-Coated Ibuprofen Asthma, Aspirin-Induced Bleeding Time Cyclooxygenase 1 Infusions, Intravenous Acetaminophen Area Under Curve Prostaglandin-Endoperoxide Synthases Gastrointestinal Hemorrhage Platelet Activation Thromboxanes Drug Resistance Half-Life Radiotherapy Planning, Computer-Assisted Cyclooxygenase 2 Inhibitors Thrombosis Risk Factors Thromboxane A2 Follow-Up Studies Dipyridamole Rats, Sprague-Dawley Dose-Response Relationship, Drug Gastric Mucosa Drug Combinations Myocardial Infarction Body Burden Thermoluminescent Dosimetry Stomach Ulcer Neoplasms Rats, Wistar Lipoxins Prostaglandins Cyclooxygenase 2 Antineoplastic Agents Drug Evaluation Drug Synergism Sulfinpyrazone Recurrence Injections, Subcutaneous Naproxen Relative Biological Effectiveness Stroke Disease Models, Animal Random Allocation Placebos Biological Availability Drug Hypersensitivity Metabolic Clearance Rate Indomethacin Dinoprostone Dogs Heparin Risk Assessment Metered Dose Inhalers Randomized Controlled Trials as Topic Radiation Monitoring Retrospective Studies Reye Syndrome Epoprostenol Radiation Injuries Clinical Trials as Topic Liver Salicylic Acid Pyrazoles Primary Prevention Antineoplastic Combined Chemotherapy Protocols

No FAQ available that match "higher doses doses of aspirin"